← Back to Search

Other

Sleep Endoscopy for Obstructive Sleep Apnea

Phase 2
Recruiting
Led By Eric J Kezirian, MD, MPH
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Patients unable to provide informed consent in English themselves
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is studying a new way to examine the upper airway in people with obstructive sleep apnea who are getting surgery for their sleep apnea. The study is finding out how well this new technique works and if it can help predict who will or will not respond to sleep apnea surgery.

Who is the study for?
This trial is for adults with obstructive sleep apnea (OSA) who are considering surgery. It's not suitable for pregnant women, minors, prisoners, those unable to consent in English, or individuals allergic to propofol or its components like soybean oil and egg lecithin.
What is being tested?
The study is testing the use of drug-induced sleep endoscopy (DISE) with Propofol sedation to evaluate upper airway issues in OSA patients. It aims to assess the reliability of DISE and compare it with other techniques like X-rays.
What are the potential side effects?
Propofol may cause side effects such as pain at the injection site, low blood pressure, drowsiness after waking up from sedation, and rarely severe allergic reactions.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot give informed consent in English by myself.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
OSA Patients considering surgical treatment

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,569 Previous Clinical Trials
10,313,495 Total Patients Enrolled
American Academy of Otolaryngology-Head and Neck Surgery FoundationOTHER
9 Previous Clinical Trials
543 Total Patients Enrolled
University of Southern CaliforniaLead Sponsor
946 Previous Clinical Trials
1,603,819 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,840 Previous Clinical Trials
8,171,823 Total Patients Enrolled
Eric J Kezirian, MD, MPHPrincipal InvestigatorUniversity of California, Los Angeles
~165 spots leftby Jun 2030
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top